Deborah Hasin, PhD
Professor of Epidemiology (in Psychiatry) at CUMC
Dr. Deborah Hasin is Professor of Clinical Epidemiology at Columbia University in the College of Physicians and Surgeons, Department of Psychiatry, with a joint appointment in the Mailman School of Public Health, Department of Epidemiology. She is an epidemiologist whose research focuses on alcohol and drug disorders and psychiatric comorbidity. She directs the Substance Dependence Research Group in the Department of Clinical Phenomenology.
Dr. Hasin has received the Senior Scientist and Mentoring award from NIAAA. She is currently a member of the DSM-V Substance Use Disorders Workgroup and the Extramural Advisory Council to the National Institute on Alcohol Abuse and Alcoholism.
She is also Associate Editor of the journal Drug and Alcohol Dependence. Dr. Hasin has consulted to or led many other national and international activities, including World Health Organization studies, and the Measurement Group for the NIDA Clinical Trials Network. Dr. Hasin has over 200 publications, including papers on the U.S. national epidemiology of alcohol and depressive disorders, on alcohol metabolizing genes, and on the course of substance and psychiatric disorders in clinical and community populations.
Dr. Hasin’s diagnostic research interview, the PRISM, is in use in numerous studies of the relationship of substance and psychiatric disorders in the U.S. and internationally.
Research interests include the epidemiology, genetics and treatment of alcohol and drug disorders, and related psychiatric comorbidity. Current studies in Dr. Hasin's group include:
(1) Personality psychopathology and alcohol/drug use disorders in the United States;
(2) Gene-environment interaction in alcohol and other phenotypes in Israel;
(3) Phenotype development for genetics studies of substance abuse disorders;
(4) Randomized clinical trial of technologically enhanced brief intervention to reduce risky drinking in HIV primary care;
(5) Randomized clinical trial of modified behavioral intervention for cocaine dependence to address cognitive deficits;
(6) Age-period-cohort effects on risk for adolescent substance use; (7) Computerized PRISM as clinician re-evaluation of survey diagnostic interview.